<sentence id="0">RIZ1 repression is associated with insulin-like growth factor-1 signaling activation in chronic myeloid leukemia cell lines .</sentence>
<sentence id="1">RIZ1 is a histone methyltransferase whose expression and activity are reduced in many cancers .</sentence>
<sentence id="2">In chronic myelogenous leukemia ( CML ) , blastic transformation is associated with loss of heterozygosity in the region where RIZ1 is located and with decreased RIZ1 expression .</sentence>
<sentence id="3">Forced RIZ1 expression in model CML blast crisis ( BC ) cell lines decreases proliferation , increases apoptosis and enhances differentiation .</sentence>
<sentence id="4">We characterized molecular mechanisms that <scope type="spec" id="0"> <cue type="spec" id="0">may</cue> contribute to potential CML tumor suppressor properties of RIZ1</scope> .</sentence>
<sentence id="5">Several RIZ1-regulated genes involved in insulin-like growth factor-1 ( IGF-1 ) signaling were identified using cDNA microarrays .</sentence>
<sentence id="6">RIZ1 was shown to associate with promoter regions of IGF-1 and to increase histone H3 lysine 9 methylation using chromatin immunoprecipitation assays .</sentence>
<sentence id="7">IGF-1-blocking antibody was used to demonstrate the importance of autocrine IGF-1 signaling in CML-BC cell line viability .</sentence>
<sentence id="8">Forced RIZ1 expression in CML-BC cell lines decreases IGF-1 receptor activation and activation of downstream signaling components extracellular signal-regulated kinase 1/2 and AKT .</sentence>
<sentence id="9">These results highlight the therapeutic <scope type="spec" id="1"> <cue type="spec" id="1">potential</cue> of inhibiting IGF-1 pathway in the acute phase of CML</scope> .</sentence>